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ABSTRACT
Today the majority of females fifteen years and older 
have used tampons. Since their introduction in 1933, 
tampons have changed greatly in composition: more 
absorbent synthetic fibers have replaced natural fibers, 
plastic applicators have joined cardboard, and some contain 
a fragrance. While changes in vaginal mucosa including 
inflammatory changes, lacerations, and micro-ulcerations as 
a result of tampon use have been documented, no research 
examining the use of menstrual hygiene products and their 
effect on cervical cytology was located.
The purpose of this study was to examine the 
association between menstrual hygiene product use and the 
incidence of abnormal Pap smear results, specifically that 
of benign cellular inflammatory changes and/or atypical 
squamous cell of undetermined significance (ASCUS). The 
Theory of Nursing as Human Science and Human Care as 
proposed by Jean Watson (1979) was the theoretical 
framework for this study.
Data were collected by chart audit review of 250 
women, ages 14 to 36, who sought Pap smear screening at a 
Midwestern family planning clinic. The data collection
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instrument was designed by the researcher. Data were 
analyzed using the Statistical Package for the Social 
Sciences (SPSS-X).
The association in Pap smear result by tampon
applicator use, analyzed using Pearson Chi square, was
. . 2found to be statistically significant (X =18.53; df=4;
p=0.003). The difference in Pap smear result by type of
2tampon was also statistically significant (X =48.06; df=3; 
p=0.000). Reported use of plastic and/or deodorized tampon 
use by those subjects with inflammatory changes and/or 
ASCUS Pap results was three times that of those reporting 





The composition of tampons has changed greatly over 
the past fifty years: more absorbent synthetic fibers have 
replaced natural fibers, plastic applicators have replaced 
cardboard, and some contain a fragrance. These changes 
warrant new studies examining tampon use and the effects of 
tampon use. "Given the increasing use of this internal 
device and the rapidity with which new products are 
manufactured and marketed, medical practitioners should 
know what products are used, how often, and for what 
purposes" (Cibulka, 1985, p. 224).
In response to the use of tampons, vaginal mucosa has 
been examined via colposcopy and tissue biopsy with results 
varying from no observable changes to the identification of 
micro-ulcerations (Friedman, 1981; Friedrich & Siegesmund, 
1980). No study exploring a relationship between tampon 
use and abnormal cervical cytology (Papanicolaou smear) was 
located.
History and Significance
Menstrual hygiene products. Today the majority of 
American females fifteen years and older have used 
tampons, which accounts in part for the billions of tampons
1
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used in a year. First marketed in 1936, the original 
tampons were made of 100% surgical cotton in a two part 
cardboard applicator. The plastic applicator tampon was 
introduced in 1967, followed by the debut of the deodorant 
tampon in 1971.
In the case of the plastic applicator, its four to six 
cusps at the end of the inserter have been reported to 
cause vaginal and cervical lacerations (Barrett, Bledsoe, 
Greer, & Droegemueller, 1979; Collins, 1979). The 
deodorant tampon is not in any way medically beneficial and 
may instead present a health hazard because the perfume may 
irritate the vaginal mucosa and the cervix and disrupt the 
normal flora of the vagina (Hasselbring, Greenwood, and 
Castleman, 1987; Horos, 1975). Perfume products, 
demonstrated to cause irritation and inflammation when 
added to sanitary pads (Fischer, 1973; Larsen, 1979), have 
not been subject to study in tampons.
Cervical cytology report. The cytological descriptive 
diagnosis of interest is that of The Bethesda System (TBS; 
Appendix A) atypical sguamous cells of undetermined 
significance (ASCUS), an epithelial cell change 
demonstrated by slight to moderate changes in nuclear size 
and morphology (Davis, Hernandez, Davis, Miyasawa, 1987; 
Montz, Monk, Fowler, Nguyen, 1992). The diagnosis ASCUS is 
limited to those cases in which cellular changes exceed 
those attributable to benign, reactive processes, but fall
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short of a definitive diagnosis of squamous intraepithelial 
lesion (Knapp, 1993).
An ASCUS Pap smear result should be further qualified, 
when possible, as to whether a reactive or a 
premalignant/malignant process is favored. Reactive 
cellular changes are associated with inflammation while 
premalignant/malignant changes are associated with squamous 
intraepithelial lesions. Reported incidence rates of this 
diagnosis for all women range from 1.6% to 19% (Davis et 
al, 1987; DHHS, 1989; Gunn & Simpson 1992; Kaminski, 
Stevens, & Wheelock 1989; Pearlstone, Grigsby, & Mutch, 
1992).
The Bethesda System for reporting cervical cytology, 
(commonly referred to as a Pap smear) provides a uniform 
format and a standardized lexicon, but it does not include 
guidelines for patient management based on TBS diagnosis. 
The contributing experts to TBS acknowledged certain 
unanswered questions exist regarding management of atypical 
cells of undetermined significance (ASCUS) and squamous 
intraepithelial lesion (SIL) (Koss, 1990).
Clinical management. Clinical management of patients 
with ASCUS Pap test results is a subject of debate. Some 
consider these minimal changes benign and recommend 
periodic repeat Pap smears at intervals ranging from three 
to twelve months. Others repeat the Pap smear immediately 
and recommend colposcopy and tissue biopsy if the atypia
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persists (Davis et al, 1987; Kaminski et al, 1989; Montz et 
al, 1992).
Nurse clinicians often manage and counsel patients 
regarding abnormal Pap smear follow-up. Upon receiving 
word of her abnormal Pap smear result, a woman may express 
anxiety which can be compounded by the questionable 
etiology of the abnormality. The nurse clinician should 
provide information about causes, diagnostic implications, 
recommendations for follow-up care, and attempt to 
alleviate patients anxieties related to the abnormal result 
(Lauver & Rubin, 1991).
It is common for the nurse clinician to recommend the 
patient avoid plastic and/or deodorized tampons in the 
interim period (commonly three to six months) between the 
initial and repeat Pap smears. Additional education 
includes avoidance of coitus, douching, or vaginal 
medications for 24-48 hours before the Pap appointment 
(Schumaker, 1991).
The nurse clinician's recommendations are guided in 
part by protocol and in part by the following principles;
(a) a healthy vagina is moist, self-cleansing and naturally 
protective against disease and odor causing germs (Horos, 
1975), (b) menstrual flow has no odor while in the vagina
and therefore a deodorant to mask odor is unnecessary 
(Friedman, 1981), (c) contact with any chemical or foreign
object on the fragile vaginal mucosa and cervix can a cause
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irritation and inflammation (Fisher, 1973; Friedrich & 
Siegesmund, 1980; Larsen, 1979), and (d) inflammation 
stimulates cell division and thus increases the chance for 
abnormal cell changes (Perez-Tamayo, 1985).
Purpose
The purpose of this study is to examine the 
association between menstrual hygiene product use and the 
incidence of Pap smear results of inflammation and/or 
atypical squamous cells of undetermined significance 
(ASCUS) in females between the ages of 14 and 36 years. 
Research Question
This study will address the following question:
What is the association between menstrual hygiene 
product use and the incidence of the Pap smear results of 
benign cellular inflammatory changes and/or atypical 
squamous cells of undetermined significance for females, 
ages 14 to 36 years, seeking services in a family planning 
setting?
Research Hypothesis
Among females ages 14 to 36 years with Pap smear 
results of benign cellular inflammatory changes and/or 
atypical squamous cells of undetermined significance, 
reported use of plastic applicator and/or deodorized tampon 
use will be greater than reported use of cardboard 
applicator/non-deodorized and/or sanitary pads.
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Theoretical Framework
Watson's (1979) Theory of Nursing as Human Science and 
Human Care lends itself well to the family planning 
setting. In daily conversation about sexuality issues, the 
nurse will draw on scientific principles and the ability to 
demonstrate transpersonal care in order to communicate 
about these historically taboo subjects (Delaney, Lupton, & 
Toth, 1976). Communication is key to providing optimal 
care, counsel and education in this nursing setting.
Person is viewed as a "being-in-the-worldM (Watson, 
1985, p. 54-55); the three spheres of 'being'--the mind, 
body and soul— are influenced by the concept of 'self'.
The 'self' is the "subjective center that experiences and 
lives within the sum total of body parts, thoughts, 
sensations, desires, memories, life history and so forth". 
The concept of self is central to the family planning nurse 
in empowering the client's decision making for her 'self'.
Environment consists of an internal and an external 
environment. The internal environment is that of mental 
and spiritual well-being and sociocultural beliefs. The 
external environment includes the variables of comfort, 
stress, privacy, safety, cleanliness and aesthetics 
(Watson, 1979). Choice of menstrual hygiene product and 
feelings related to a female's menstrual cycle are integral 
to the internal and external environments as described by
Watson.
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Health is an elusive, relative concept and is 
individually defined. It is, Watson (1979, p. 219) states, 
:he "process of adapting, coping and growing that goes on 
:rom conception to death".
Nursing is a "therapeutic interpersonal process" 
(Watson, 1979, p. 7). Nursing is involved with the 
restoration, maintenance, and promotion of health and 
prevention of illness. Watson speaks of nursing as an art 
and a science, more specifically a human science.
The structure for studying and understanding nursing 
as a science of caring is formed by Watson's ten carative 
factors (Watson, 1979, pp. 9-10). Two factors have 
significance for this study. They are as follow:
1. Carative Factor 6: The systematic use of 
the scientific problem-solving method for 
decision making; and
2. Carative Factor 7: The promotion of 
interpersonal teaching-learning.
The family planning nurse will gather data from the 
client, i. e., Pap smear, menstrual history, psycho-sexual 
history, and menstrual hygiene practices. Applying the 
scientific problem solving method, the nurse will examine 
the association between the use of plastic applicator 
and/or deodorant tampons and the incidence of ASCUS Pap
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smears. Abnormal Pap smear follow-up counsel and education 
will, in part, reflect the findings of this study. 
Definitions
The following terms have been defined for the purposes 
of this study:
Papanicolaou (Pap) smear consists of a sample of cells 
from the epithelial surfaces of the uterine cervix placed 
on a microscope slide, stained and studied under a 
microscope by a cytopathologist or cytotechnologist. It is 
a simple screening tool for cervical neoplasia and other 
abnormalities (Koss, 1990). This specimen is also called a 
cervical cytological smear.
Abnormal Pap smear includes only those Pap smear 
results with either reported benign cellular inflammatory 
changes or the TBS descriptive diagnosis of atypical 
squamous cells of undetermined significance (ASCUS). 
Previously this abnormal finding was classified as a Class 
II Pap smear based on the Papanicolaou Classification 
System (see Appendix B).
Tampon refers to a plug made of cotton and/or 
synthetic fibers introduced into the vagina typically to 
absorb menstrual flow. The term "type of applicator" 
refers to plastic, cardboard or non-applicator tampons.
The term "type of tampon" refers to deodorized or 
non-deodorized tampons.
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Cardboard applicator refers to a tampon contained 
within a cardboard applicator.
Plastic applicator tampon refers to a tampon contained 
within a plastic applicator intended to ease insertion.
Deodorant tampon refers to a tampon containing a 
fragrance intended to mask odor of menstrual flow.
Adolescent Onset (AO) appears on the data collection 
instrument and refers to age at initiation of sexual 
intercourse; in this case, prior to the age of 19 years.
Birth control method (BCM) appears on the data 
collection instrument and refers to any intervention 
including hormonal, barrier, or fertility awareness, used 
to control a woman's fertility.
Multiple Contacts (MC) appears on the data collection 
instrument and refers to number of lifetime sexual 
partners; in this case, greater than one sexual partner in 
preceding seven years.
Sexually Active (SA) appears on the data collection 
instrument. The frequency of sexual activity will be 
described as frequent: greater or equal to two acts of 
intercourse per week or infrequent: less than two acts of 
intercourse per week.
Limitations
Generalizability of findings may be limited due to 




This review of selected references will provide 
background information on cervical cytology specifically 
the Papanicolaou smear (Pap smear), its reporting system, 
previously identified predictors of abnormal cervical 
cytology, and menstrual hygiene products with emphasis on 
tampons.
Cervical Cytologic Smear Reporting System
The cervical/vaginal cytologic smear, commonly known 
as a Pap smear, was first introduced in 1943 by Dr. George 
Papanicolaou, hence its name. Cell samples, obtained from 
the cervix and vagina, are stained by the Papanicolaou 
method, microscopically examined, and interpreted by a 
cytopathologist. The screening test is largely responsible 
for the 70% decrease in morbidity and mortality resulting 
from cervical cancer over the past forty years (Koss, 1990; 
Lundberg, 1989; U. S. DHHS, 1989). The Pap smear is 
simple, painless and "one of the most accurate and cost 
effective medical tests" (DHHS, p. 3).
Papanicolaou classification system. According to Koss 
(1990 p. 988), Papanicolaou recognized "that he was not 
qualified to render diagnostic verdicts based on the
10
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smear". Thus, he devised a five class system of reporting 
Pap smear results (Appendix B). This system has been 
widely accepted in the United States; however, laboratories 
may differ in the way in which they use the system's 
terminology. These variations may significantly alter the 
clinical implications of the Pap smear report. Recent 
controversy regarding the Pap system of reporting, its 
varied and sometimes ambiguous terminology, and quality 
assurance are reflected in the literature (Koss, 1989; 
Lundberg, 1989) .
The Bethesda System. Under the auspices of the 
National Cancer Institute, a multidisciplinary group of 
experts convened in Bethesda, Maryland, in December of 
1988. The purpose of the meeting was to address the 
standardization of cervical/vaginal cytology reports. The 
resulting system, The Bethesda System was adopted by 
consensus and gained widespread support in laboratory 
practice. TBS offers a uniform format and provides a 
standardized lexicon for cervical cytology reports, 
specifically emphasizing communication of clinically 
relevant information (Knapp, 1993).
Re-evaluation and revisions to TBS were made when the 
group reconvened in 1991. While TBS does not include 
guidelines for patient management, the desire for such 
guidelines was emphasized at this second meeting. The 
contributors called for additional research and clinical
12
trials to resolve certain unanswered questions regarding 
management of ASCUS and low grade lesions (Knapp, 1993). 
Predictors of Abnormal Cervical Cytology
Sexual factors. Various indicators of sexual activity 
have long been known to be associated with cervical cancer, 
and a large number of epidemiological studies have been 
carried out on this subject. Studies indicate that age at 
first intercourse, multiple sexual partners, and having a 
male partner with multiple partners are associated with the 
risk of developing cervical cancer. This has prompted a 
search for one or more sexually transmitted diseases (STDs) 
which play a role in the pathogenesis of cervical cell 
abnormalities (Berger, 1978; Buckley, Doll, Harris, 1981; 
Clarke, Hatcher, McKeon-Eyssen, 1985; Montz, Monk, Fowler, 
Nguyen, 1992; Slattery, Overall, Abbott, French, Robison, & 
Garner, 1989; Vessey & Williams, 1981; Wright & Riopel, 
1984; Wynder, 1969).
Contraceptives. Several epidemiological studies of 
the relationship between oral contraceptives (OC) and 
cervical neoplasia have yielded conflicting results. This 
may be in part due to the fact that OC use is strongly 
correlated with the aforementioned key sexual risk factors 
and the degree of adjustment for these confounding 
variables among studies (Brinton, et al., 1986; Clarke, 
Hatcher, McKeown-Eyssen, & Lickrish, 1985; Irwin, et al., 
1988).
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If an STD is the major cause of cervical cancer, a 
protective effect of barrier contraception should be 
expected. Spermicides and condoms may be protective 
(Celentano, Klassen, Weisman, & Rosenhein, 1987), while the 
cervical cap may actually increase the risk of cervical 
cell abnormalities (Berstein, 1986).
Smoking. An association between cigarette smoking and 
cervical cancer was first proposed over 15 years ago.
Recent studies revealed an approximately two-fold increase 
in risk for smokers versus non-smokers, and a clear 
dose-response relationship was observed in two of these 
studies (Brinton, Schairer, Haenszel, Stolley, Lehman, 
Levine, & Savitz, 1986; Clark, Hatcher, McKeown-Eyssen, & 
Lickrish, 1985; Mitchell, Sandeila & White, 1992; and 
Trevathan et al., 1983).
Tampons
Historical perspective. Although "invented" in 1933 
by an American physician, documentation of tampon use by 
women dates back to the fifteenth century B.C. Tampon 
composition varied among cultures. Roman women used soft 
wool; Egyptian women, papyrus; Japanese women chose paper; 
and women of African and Asian cultures used a variety of 
plants to construct internal vaginal guards to be worn 
during menstruation (Delaney, Lupton, & Toth, 1976, ; 
Friedman, 1981).
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The first tampons to be marketed in the United States 
were made of 100% cotton; most were compressed within a two 
part cardboard applicator. By the 1970s, rayon was 
combined with or replaced cotton in nearly every tampon on 
the market. The tampons of today are made of combinations 
of rayon and synthetic fibers, and can be purchased with a 
cardboard or plastic applicator, or with no applicator at 
all. (Delaney et al. , 1976, 198.8; Friedman, 1981, Friefeld, 
1984). Fragrance first appeared in tampons in 1971. The 
intent was that American women could have a the combination 
of a "soft and gentle" tampon with a "fresh, delicate 
scent" (Friedman, 1981, p. 51). A perfumed product was, 
and still is, promoted as a deodorant product.
Tampons were classified by the Food and Drug 
Administration (FDA) as a cosmetic from 1938 to 1968. As a 
cosmetic, tampons were considered outside the realm of 
federal regulation. In 1968, tampons became a Class I 
medical device, and in 1980 were reclassified as a Class II 
medical device, thereby subject to FDA performance 
standards, if and when such standards are developed.
Cibulka (1983) reports consumer groups are advocating the 
change from a Class II to a Class III medical device. This 
change would subject tampons to rigorous pre-market testing 
for effectiveness and safety.
In 1982, the FDA required tampon manufacturers to 
include standardized warning labels and package inserts
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advising consumers of the risks and symptoms of Toxic Shock 
Syndrome (TSS), a rare but sometimes fatal disease 
associated with tampon use. The FDA also recommended those 
women using tampons use the least absorbent tampon 
necessary for absorption of menstrual flow. (Consumer 
Reports, 1986; Friefeld, 1984; Nightingale, 1990).
FDA testing demonstrated that terms used to signify 
absorbency such as "regular" and "super" varied in meaning 
among tampon manufacturers. As a result of the findings, 
the FDA ruled that beginning March 1, 1990, the following 
terms would be uniform among tampon manufacturers and were 
to appear on package labeling: junior (6 grams or less of 
fluid absorbed per tampon; regular (6 to 9 grams); super (9 
to 12 grams); and super plus (12 to 15 grams) (Consumer 
Reports, 1986, 1990; Nightingale, 1990). Tampon 
manufacturers are not required to list ingredients, 
including composition of fibers or perfume additives, at 
this time.
Composition. Prior to 1977, tampons were made of 
cotton, rayon, or a combination of the two. Since then, 
the composition of tampons has changed to include more 
absorbent synthetic materials. In some tampon users this 
increased absorbency has been detrimental. Extensive 
research supports the association between absorbency and an 
increased risk for TSS. Toxin producing Staphylococcus 
aureus and tampon use have been implicated as causative
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factors in the development of TSS; the exact nature of the 
relationship is not yet clearly understood (Cibulka, 1983; 
Consumer Reports, 1986; Finkelstein & Von Eye, 1990;
Friefeld, 1984; Irwin & Millstein, 1982; Nightingale,
1990).
Perfume was added to tampons in 1971 and the product 
was designated a deodorant (not scented) tampon (Friedman, 
1981; Larsen, 1979). Fisher (1973) reported that several 
documented cases of irritation and dermatitis secondary to 
use of perfumed feminine hygiene sprays appear in the 
literature. Larsen documents the occurrence of vulvar 
dermatitis which was a result of the perfume in a deodorant 
sanitary napkin.
Absorbency. The concept of absorbency is the focus of 
several reports on tampons. Early researchers regarded 
absorbency in terms of "complete protection" (Arnold and 
Hegele, 1938, p. 792) or the ability of a tampon to absorb 
the menstrual flow without the additional use of a sanitary 
napkin. The studies of Arnold and Hegele and Thornton 
(1943) suggest that early tampons, made of cotton fibers, 
did not afford complete protection for the majority of 
women using them. •Based on their limited knowledge of how 
susceptible the vaginal mucosa was to repeated irritation, 
the early researchers concluded that "when tampons are used
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regularly during the menstrual period, periodic examination 
of the vagina should be made to ascertain whether the 
mucosa remains normal" (Arnold & Hegele, 1938, p. 791).
Friedrich and Siegesmund (1980) examined absorbency of 
tampons in relation to alterations in vaginal mucosa 
revealed by colposcopic evaluation. The researchers 
conducted a blind, random study of one hundred and sixty 
women using tampons either during periods or between 
periods. Tampons were identified as either 
"superabsorbent" or "non-superabsorbent"; no deodorant 
tampons were used. The researchers concluded that 
superabsorbent tampons are significantly more likely to 
produce micro-ulcerations than non-superabsorbant tampons 
when used intermenstrual.ly. Furthermore, chronic 
production of these alterations could lead to clinically 
visible lesions of the vagina.
Safety and comfort. Concepts of safety and comfort 
are addressed in early literature about tampons. Most 
researchers reported in favor of tampon use and found that, 
among their subjects, tampons were a generally safe, 
comfortable, effective way of managing menstrual flow 
(Arnold & Hegele, 1938; Barton, 1942; Dickinson, 1945;
Magid Sc Geiger, 1942 ; Thornton, 1943 ; Wheatley, Menkin, 
Bardes, Sc Rock, 1965; Widenius, 1944).
Moral implications. The use of tampons created a 
moral dilemma for some, including clergy, physicians and
18
consumers. It was believed a tampon could possibly rupture 
the vaginal hymen of a virginal woman thereby being an 
agent of defloration (Barton, 1942; Singleton & Vanorden, 
1943). In 1945, Dr. Karnaky, who had conducted a five year 
study of 42 women, declared the tampon safe for "unmarried 
women" (Friedman, 1981, p. 45). In a review paper, 
Dickinson (1945, p. 490) explored and compared the 
eroticism of the "internal and external menstrual guards".
Therapeutic use. Researchers in the late 1950s and 
early 1960s advocated the use of tampons in the treatment 
of vaginitis (Friedman, 1981; Karnaky, 1956). According to 
Triedman, Karnaky also recommended tampon use as an aid in 
managing infertility, but, he did not provide specific 
support for this recommendation. Rutherford, Banks and 
Coburn (1962) advocated the therapeutic use of tampons in 
postpartum lochia flow. Lamb and Berg (1985) examined the 
potential role of vaginal tampons in women with 
endometriosis.
Injuries. Several case studies describing the 
incidence of tampon associated ulcerations and lacerations 
appear in the literature (Barrett, Bledsoe, Greer, & 
Droegemueller, 1977; Collins, 1979; Jimerson & Becker,
1980; Weissberg & Dodson, 1980). Barrett et al. suggest 
pressure necrosis or chemical irritation as the mechanism 
of ulcer formation in the cases they reported. Collins 
(1979, p. 127) attributed a one to two millimeter tear
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which resulted in "a life threatening hemorrhage" to the 
cusp of a plastic inserter and asserted that foreign body 
insertion is the major noncoital cause of vaginal injury".
Related variables. The studies of Irwin and Millstein 
(1982) and Finkelstein and Von Eye (1990) suggest that 
physicians and nurses do not fully understand the 
relationships of age, racial-ethnic differences, patterns 
of sanitary product use, and the role they play in the 
production of TSS. The researchers encouraged further 
study of sanitary product use with consideration of 
additional variables including socioeconomic status.
CHAPTER III
METHODOLOGY
The purpose of this study was to describe the 
association between menstrual hygiene product use and the 
incidence of Pap smear results of inflammatory changes 
and/or atypical squamous cells of undetermined 
significance. In this chapter the study sample, 
methodology, and proposed data analysis will be described. 
Population
The target population was females, ages 14 to 36 
years, who use tampons during a menstrual period. The 
accessible population was that of females, ages 14 to 36 
years, who sought services at a Midwestern family planning 
clinic.
Study Design
The study was non-experimental in nature. It was a 
retrospective exploratory study of menstrual hygiene 
product use and the resulting incidence of abnormal Pap 
smear results.
Sampling method. The sample group was 250 females, 
who sought a Pap smear in the 6 month time period of 
November, 1992 through April, 1993. Subjects were selected 
at random from the 1364 women whose names appeared in the
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clinic lab log. Entries were numbered consecutively, and a 
table of random numbers used to select cases for study.
Of the 400 charts selected 150 were excluded from the study 
for the following reasons: abnormal Pap smear within the 
preceding 15 months, (n=25; 7%); repeat Pap smear following 
an abnormal (n=57; 38%); age (n=7; 5%); and incomplete data 
base (n=61; 40%). The remaining 250 charts were used in 
data collection.
Protection of human subjects. The study was in 
compliance with the legal reguirements governing human 
subjects research, as set forth by both the Institutional 
Review Board and the Department of Health and Human 
Services (Department of Health and Human Services 1990; 
Institutional Review Board, 1989) . This project was 
subject to "exempt'1 review because it is a study of 
existing data, documents or records.
Data Collection Method
Data were collected by chart audit review. Responses 
to questions regarding menstrual hygiene product use are 
recorded in each client's chart as part of the health 
history. Data were located and transferred to the data 
sheet described below. Data collection began upon approval 




The data collection instrument was designed by the 
researcher (Appendix C). It included data related to age, 
adolescent onset of sexual intercourse, history of multiple 
sexual partners, frequency of sexual activity, birth 
control method, menstrual hygiene product use, age at first 
use, smoking status and the Pap smear result.
Data Analysis
The association between menstrual hygiene product use 
and non-malignant Pap smear results was evaluated by 
Pearson Chi square analysis of the cross classification of 
the two factors (Kirk, 1990). Separate analysis were 
conducted for applicator type and deodorant presence in 
tampons. The overall Type I error rate (alpha) was set at 
.05; Bonferroni's approach, was used to control the 
experiment wise Type I error rate (Kirk, 1982), so the 
nominal alpha was .025 for each test. Other data were 
analyzed using the Student's t-test and descriptive 




In this chapter the findings of data analysis will be 
presented. The sample profile will be discussed followed 
by the research question and hypothesis outcomes, and 
additional findings of interest. Data were analyzed using 
the Statistical Package for the Social Sciences— Revised 
(SPSS-X).
Sample Profile
The sample profile results are portrayed in Table 1. 
The subjects ranged .in age from 14 to 36 years (X=22.2 
years; N=250; SD=4.3). Nearly three fourths of the females 
reported adolescent onset of intercourse (n=185; 74%), 
compared to 65 (26%) who had abstained until the age of 19 
years. Multiple sexual contacts were reported by 198 (79%) 
respondents while 52 (21%) reported only one lifetime 
sexual partner. Eighty three (33%) respondents report 
frequency of sexual intercourse to be less than two acts of 
intercourse per week, while sixty one (25%) reported 
intercourse occurred two or more times per week; missing 
data (n=106; 42%). The vast majority of females used oral 
contraceptives as a birth control method (n=224; 90%), 
while 11 (4%) used condoms, 2 (1%) used spermicides, 2 (1%)
23
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used diaphragms, and 11 (4%) relied on other birth control 
methods (e. g. fertility awareness, sponge, sterilization, 
withdrawal, and none). Cigarette smoking was reported by 
53 (21%) of the females; the remaining 197 (79%) were 
non-smokers.
Tampon use was reported by 189 (76%; n=250) of the
females while 61 (24%) used sanitary pads only. Age of 
first use of tampons ranged from 9 to 21 years with a mean 
of 14 years (SD=6.5; n=250). With regard to tampon 
applicator type 76 (27%) used plastic applicators, 88 (35%) 
used cardboard applicators, 29 (12%) used either 
applicator, (2%) used non-applicator tampons. With regard 
to type of tampon the majority of females selected 
non-deodorized tampons (n=131, 52%), compared to those who 
used deodorized tampons (n=38; 15%), either type (n=20;
8%). One hundred twenty five of the females reported using 
0 to 4 tampons per day (50%) compared to 61 (24%) who used 
5 ana 8 tampons per day, and 3 (1%) who used 9 to 12 
tampons per day.
Sanitary pad use was reported by 221 (88%) of the 
females compared to 29 (12%) who reported non-use of pads 
(n=250). Non-deodorant pads were used by the vast majority 
(n=211; 84%). Deodorant pads were used by 4 (2%) females 
and 6 (2%) reported using either type of product.
Pap smear results of within normal limits (WNL) were 
reported in 201 (80%) of the cases, compared with 30 (12%)
25
ASCUS results, 4 (2%) LSIL results, 11 (4%) benign cellular 
inflammatory changes, and 4 (2%) other results. Combining
the Pap results of ASCUS and benign cellular inflammatory 
changes, a total of 41 (16%) Pap results met the criteria 
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('Table 1. Sample Profile, continued)
Birth Control Method









Non Applicator 2 5
Non Use 24 61
Type of Tampon
Deodorant 15 38
Non Deodorant 52 131
Both 8 20
Non Use 25 61




Non Use 25 61
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Characteristic Mean SD Range n
Age 22.2 4.3 14-36 yrs 250
Age At First Tampon Use 14.6 1.9 9-21 yrs 250
N=2 50
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Examination of the Research Question and Hypothesis
The research question was: What is the association 
between the type of menstrual hygiene product used and the 
incidence of the Pap smear results of benign cellular 
inflammatory changes and/or atypical squamous cells of 
undetermined significance for females, ages 14 to 16 years, 
in a family planning setting?
The research hypothesis was: Among females ages 14 to 
36 years with Pap smear results of benign cellular 
inflammatory changes and/or atypical squamous cells of 
undetermined sig .ificance, reported use of plastic 
applicator and/or deodorized tampons will be greater than 
reported use of cardboard applicator/non-deodorized and/or 
sanitary pads.
Eight cases were excluded in statistical analysis:
Pap results of low grade squamous intraepithelial lesions 
(n=4; 2%) and Pap results of "other" (n=4; 2%). Tables 2 
and 3 list the cross-tabulation of abnormal Pap smear 
results with applicator type and deodorant type, 
respectively. The research hypotheses regarding applicator 
and deodorant type were supported from a statistical 
perspective. Pap smear results by type of applicator 
(plastic, cardboard, non-applicator) used were 
significantly different as noted by Pearson Chi square 
results (X2=18.853; df=4; p=0.003; N=242).
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Pap smear results by deodorant type used were significantly 
different (X2=48.06; df=3; p=0.000? N=242).
Among those subjects with abnormal Pap results (n=41) 
reported use of plastic applicators (n=17; 41%) was nearly 
three times that of use of cardboard applicators (n=6;
14%); and twice that of reported use of pads (n=9; 22%). 
Furthermore, among these same subjects reported use of 
deodorant tampons (n=17; 41%) was nearly three times that 
of non-deodorant (n=6; 14.6%); and twice that of reported 
use of pads (n=9; 15%).
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Table 2








Plastic 73.4 2 6.6 26.4
23.4 41.5
80 6 86
Cardboard 93.0 7.0 3 5.5
39.8 14.6
19 9 28







Non-Use 85.0 15.0 24.8
(pads) 25.4 22.0
COLUMN 201 41 242
TOTAL 83.1 16.9 100.0
Value df E
Pearson Chi Square 15.9 4 0.003
Table 3
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Deodorant 54.1 45.9 15.3
10.0 41.5
120 6 126
Non-Deodorant 95.2 4.8 52.1
59.7 14.6
10 9 19
Either 52.6 47.4 7.9
5.0 22.0
51 9 60
Non-Use 85.0 15.0 24.8
25.4 22.0
COLUMN 201 41 242
TOTAL 83.1 16.9 100.0
Value df E
Pearson Chi Square 48.06 3 0.0000
Additional Findings
Incidence of abnormal Pap smears is significantly 
greater in those who experienced initial intercourse during 









Col Pet 0 1 ROW
Norma] Abnormal TOTAL
AdolesuenL Onset.
Of Intercourse 154 25 179
Yes 86.0 14.0 74.0
76.6 61.0
47 16 63
No 74.6 25.4 26.0
23.4 39.0
COLUMN 201 41 242
TOTAL 83.1 16.9 100.0
Value df
Pearson Chi Square 4.33* 1
*p < 0.05
Student t-tests of Pap by age and Pap by age at first 
use were calculated. The mean age of the two groups, 
normal and abnormal Pap results, differed significantly 
(t=-2.05; df=240; p=0.04). Table 5 presents the results. 
T-test for age at first use was non-significant.
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Table 5
Students t-test Of Mean Age By Pap Result
N Mean SD t df P
Age




Group 2 41 
(Abnormal Pap)
23.4 4.5
When Chi square was used to determine differences in 
Pap results by the following variables there were no 
significant differences: multiple sexual contacts,
(X2=3.67; df=l; p=NS; N=242); frequency of sexual
2intercourse (X =1.58; df=2; p=NS); birth control method 
2(X =2.39; df=5; p=NS); number of tampons used per day
(X£'=2.2 0 ; df =3) ; use of pads (X2=2.49; df=3 ; p=NS) ; and 
. 2smoking status (X =1.09; df=l; p=NS).
CHAPTER V
DISCUSSION
This chapter will provide a brief summary of the 
study. Discussion and conclusions will be presented 
followed by recommendations for practice, education, 
research and policy.
Summary
Today the majority of females fifteen years and older 
have used tampons. Since their introduction in 1933, 
tampons have changed greatly in composition: more 
absorbent synthetic fibers have replaced natural fibers, 
plastic applicators have joined cardboard, and some contain 
a fragrance. While changes in vaginal mucosa including 
inflammatory changes, lacerations, and micro-ulcerations as 
a result of tampon use have been documented, no research 
examining the use of menstrual hygiene products and their 
effect on cervical cytology was located.
The purpose of this study was to examine the 
association between menstrual hygiene product use and the 
incidence of abnormal Pap smear results. The Pap smear 
result of interest was that of benign cellular inflammatory 




Data were collected by chart audit review of 250 
women, ages 14 to 36, who sought Pap smear screening at a 
Midwestern family planning clinic. The data collection 
instrument was designed by the researcher. Data were 
analyzed using the Statistical Package for the Social 
Sciences (SPSS-X).
The association in Pap smear result by tampon
applicator use, analyzed using Pearson Chi square, was
2found to be statistically significant (X =18.53; df=4;
p=0.003). The difference in Pap smear result by type of
2tampon was also statistically significant (X =48.06; df=3;
p=0.000).
Discussion
Review of the literature. The current literature 
suggests that ASCUS Pap smears occur at a frequency of 1.6 
to 19% (Davis et al,; 1987; DHHS, 1989; Gunn & Simpson, 
1992; Kaminski et al., 1989; Pearlstone et al., 1992). The 
study results indicate an incidence rate of 12% and thus 
remain consistent with previously documented incidence 
rates.
While risk factors for benign cellular changes and 
atypia have not been extensively studied or reported in the 
literature, those for cervical cancer have been identified. 
Among factors identified as altering risk for cancer are 
those related to age, sexual behavior, contraceptive 
methods, and cigarette smoking (Berger, 1978; Brinton et
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al., 1986; Celentano, Klassen, Weisman, & Rosenhein, 1987; 
Clarke et al., 1985; Irwin, 1988; Trevathan, 1983).
The results of this study indicate type of tampon 
(deodorant, non-deodorant) and type of applicator 
(plastic, cardboard, non-applicator) were associated with 
the increased possibility of an abnormal Pap result of 
benign cellular inflammatory changes and/or ASCUS. This 
finding is consistent with principles of vaginal health: 
contact with any chemical or foreign object on the fragile 
mucosa can cause irritation and inflammation (Fisher, 1973; 
Friedrich & Siegesmund, 1980; Larson, 1979), and 
inflammation stimulates cell division thereby increasing 
the chance for abnormal cell changes (Perez-Tamayo, 1985).
The results of this study support the findings that 
adolescent onset of sexual intercourse is associated with 
an increased likelihood of an abnormal Pap smear result 
(see Table 4). A Student's t-test was significant for the 
relationship between age and Pap smear result (see Table 
5) .
In this study, results indicate the differences 
between history of multiple sexual contacts, birth control 
method, and smoking status by Pap smear result are 
determined to be non-significant. The results do not 
support previously evidenced associations; however these 
other studies reviewed malignant findings while this study 
reviewed non-malignant Pap results.
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A survey of the literature reveals a limited number of 
articles regarding tampon usage with the exception of those 
which are directly related to TSS. From 1938 to 1966, 
articles in the medical literature debated clinical and 
moral issues involving tampon use. Researchers concluded 
that tampons were a safe and effective means for the 
absorption of menstrual fluid (Arnold & Hegele, 1938; 
Barton, 1942; Dickinson, 1945; Karnaky, 1956; Rutherford et 
al., 1962; Thornton, 1943; Widenius, 1944). When it was 
discovered, in the late 1950s, that the deep vaginal mucosa 
lacked any specific nerve endings, the focus on tampons and 
its implications for morality diminished (Wheatley et al., 
1965). The literature review revealed no documented 
studies of tampons usage in the medical literature from 
1966 to 1977.
The literature of the late 1970's and early 1980s 
evidenced a growing concern for the incidence of 
tampon-induced lacerations and ulcerations. However, this 
concern was overshadowed in July, 1980, by the newly 
diagnosed, tampon-associated Toxic Shock Syndrome.
Why the dearth of information regarding such a common 
practice such as tampon use in menstruating females? No 
doubt, the low social status of women in times past, and 
the taboos, myths, and superstitions, which even now, 
surround menstruation have been important factors.
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Theoretical framework. The Theory of Nursing as Human 
Science and Human Care as proposed by Jean Watson (1979) 
provided the theoretical framework for this study. In 
daily conversation about sexuality issues the nurse draws 
on scientific principles and the ability to demonstrate 
transpersonal care in order to communicate about these 
historically taboo subjects. Two of Watson's ten Carative 
Factors--Carative Factor 6: the systematic use of the 
scientific problem-solving method for decision making? and 
Carative Factor 7: the promotion of interpersonal teaching 
and learning had significance for this study. Applying the 
scientific problem solving method, the researcher examined 
the association between the use of menstrual hygiene 
products and incidence of abnormal Pap smear results. The 
process provided the opportunity to be engaged in the 
interpersonal teaching and learning process with 
professors, co-workers, and clients
Implications for practice. The nurse clinician's role 
in cervical cytology screening and the prevention, 
detection, and follow-up care of abnormal Pap smears 
includes the responsibilities of patient education, 
consultation, and consumer advocacy. The nurse's 
responsibilities require expertise in detection skills, 
quality assurance and control, the maintenance of a 
therapeutic environment for learning, and ongoing critical 
analysis of potential causal relationships that can alter 
Pap smear findings.
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Patient education is guided in part by protocol and 
ased on principles of vaginal health. The nurse clinician 
ust provide an explanation of the reason for Pap screening 
nd evaluate the learning needs of the patient regarding 
isk behaviors. The nurse should recognize and attempt to 
iminish the patient's negative emotions regarding the Pap 
mear result.
Consultation involves nurses in collaboration with 
hysicians, cytopathologists, and cytotechnologists (list 
ot exclusive) performing periodic review of patient 
istories and identification of high risk factors, 
ducation on methods, materials, and considerations for 
sliable Pap screening are necessary. Ginsberg (1991) 
uggests standardized educational protocols for health care 
roviders to encourage uniform Pap screening are warranted.
Nurses as consumer advocates for health must 
antribute to the establishment of standardized protocols 
ar abnormal Pap smear management. Nurses can promote 
anfidence in Pap smear screening by educating the 
ammunity via newspaper, public service announcements, and 
gencies who serve women. Nurses can join with consumer 
roups to urge tampon manufacturers to list ingredients; 
tie Menstrual Wealth Catalog (1993) reports incidence of 
axes, surfactants, alcohols, acids, nitrogen compounds, 
nd hydrocarbons being leached from tampons and pads. As 
dvocates for women's health, nurses must increase self and
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other awareness about the potential damage to the 
environment resulting from the disposal of plastic and 
paper menstrual hygiene products, approximated to be 11.5 
billion pounds per year (Menstrual Wealth Catalog, 1993).
Basic nursing curricula need to include content on 
eliciting a complete psycho/social/gynecologicc.l history.
A complete history should include, but not be limited to, 
information regarding sexual behavior, contraception, 
smoking status, menstrual history, and feminine hygiene 
practices including use of menstrual hygiene products and 
douching. Furthermore, nurses should be aware of the 
potential risks associated with these components of the 
patient history.
Recommendations for Further Research
Replicating this study using a larger sample, or a 
continuation of this presented study, to strengthen the 
generalizability of the results would be useful. For ease 
in data collection, the data regarding menstrual hygiene 
product use could be incorporated into the cervical 
cytology lab slip submitted with the specimen.
A longitudinal study of females with ASCUS Pap results 
could examine the frequency in which atypia persisted or 
recurred over time with consideration for
continued/discontinued use of a specific menstrual hygiene
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product. Concurrently, the natural history of the 
cytological changes could be examined.
A survey could be undertaken to determine female's 
reasons for choosing particular menstrual hygiene products, 
feelings about menstruation and the need for such products, 
and patient identified concerns regarding use of such 
products. Given the prevalence of use of tampons and the 
rapidity with which new products are introduced, nurse 
clinicians should know what products are used, how often, 




THE BETHESDA SYSTEM FOR
REPORTING OF CERVICAL CYTOLOGICAL SMEARS
The cytopathologist's cervical smear report will




less than optimal, limited by;
General Categorization of specimen:








non-epithelial malignant neoplasm: 






THE PAPANICOLAOU CLASSIFICATION SYSTEM
Class 0 few cells; white blood cells, red 
blood cells, dried; distorted cells 
broken slide






Less than 10% basal or 
undifferentiated cells 
Histology: Atypical Squamous cells




Greater than 30% Basal or 
undifferentiated cells on slide 
Histology: Severe dysplasia 
Carcinoma in situ
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